CANTON-POTSDAM HOSPITAL

CCN 330197

Price-file publication check · 45 CFR § 180
F · 55
This hospital's published file contains little of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
20,889
Insurances with rates
11
CPT / HCPCS codes
13,112
Source MRF
File last updated: 2026-04-01 (per the hospital's file)
Retrieved: 2026-11-02

Most expensive procedures (gross)

25682-028-01
$119,052
RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [190114]
Gross
$183,157
25682-025-0125682-028-01
$100,292
RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [190114]
Gross
$154,296
50242-150-01
$60,154
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION [178568]
Gross
$92,544
0003-7125-11
$48,726
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION [194379]
Gross
$74,963
75987-080-10
$44,008
PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION [148751]
Gross
$67,705
0469-4425-30
$39,000
ZOLBETUXIMAB-CLZB 300 MG INTRAVENOUS SOLUTION [205659]
Gross
$60,000
0173-0898-03
$38,162
DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION [191781]
Gross
$58,710
0003-2328-22
$32,560
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION [150564]
Gross
$50,093
51144-050-01
$29,050
BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION [153019]
Gross
$44,692
72493-103-03
$27,242
MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT [188495]
Gross
$41,911
72903-853-01
$26,710
MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION [195098]
Gross
$41,092
47335-177-95
$24,865
TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE [182767]
Gross
$38,254
57894-505-20
$24,676
DARATUMUMAB 20 MG/ML INTRAVENOUS SOLUTION [173332]
Gross
$37,964
59572-775-01
$24,333
LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION [187194]
Gross
$37,435
50881-006-03
$23,957
RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION [197773]
Gross
$36,858
57894-501-01
$23,701
AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION [192080]
Gross
$36,463
0006-3026-04
$20,000
PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [169519]
Gross
$30,770
0310-4611-50
$19,537
DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION [179453]
Gross
$30,057
76100272
$18,947
HC BRONCHOSCOPY W_PLMT FIDUCIAL MARKERS SINGLE_MULT
Gross
$29,150
50242-917-01
$18,555
ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION [175551]
Gross
$28,546
61755-008-01
$17,722
CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION [183555]
Gross
$27,265
57894-470-01
$17,449
TALQUETAMAB-TGVS 40 MG/ML SUBCUTANEOUS SOLUTION [199466]
Gross
$26,845
0003-3734-13
$16,869
NIVOLUMAB 100 MG/10 ML INTRAVENOUS SOLUTION [169181]
Gross
$25,952
57894-503-01
$16,842
DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN [188662]
Gross
$25,911
73475-3041-5
$16,715
EFGARTIGIMOD ALFA-FCAB (VYVGART) INFUSION [4083352]
Gross
$25,715
0074-5015-01
$16,706
RISANKIZUMAB (SKYRIZI) INFUSION [4083277]
Gross
$25,702
0003-2327-11
$16,633
IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION [150563]
Gross
$25,589
50242-061-01
$15,540
BEVACIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [38022]
Gross
$23,908
15054-1120-4
$15,538
LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE [87861]
Gross
$23,905
0173-0892-42
$15,206
MEPOLIZUMAB 100 MG/ML SUBCUTANEOUS SYRINGE [185700]
Gross
$23,394
50242-260-01
$14,601
PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONID-ZZXF/10 ML SUBCUT SOLN [189241]
Gross
$22,463
51144-020-01
$13,514
ENFORTUMAB VEDOTIN-EJFV 20 MG INTRAVENOUS SOLUTION [187475]
Gross
$20,790
50242-053-06
$13,314
RITUXIMAB 10 MG/ML CONCENTRATE,INTRAVENOUS [22149]
Gross
$20,484
64406-008-01
$13,276
NATALIZUMAB (TYSABRI) INFUSION CPH [4083297]
Gross
$20,424
64764-300-20
$13,036
VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION [166819]
Gross
$20,055
68727-712-01
$12,652
LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION [189006]
Gross
$19,464
50242-176-01
$12,566
TENECTEPLASE 50 MG INTRAVENOUS SOLUTION [181909]
Gross
$19,333
36100063
$11,765
HC TRANSPERINEAL PLMT BIODEGRADABLE MATRL 1_MLT NJX
Gross
$18,100
57894-054-27
$11,489
USTEKINUMAB 130 MG/26 ML INTRAVENOUS SOLUTION [177086]
Gross
$17,675
51010333
$11,466
HC NASAL_SINUS NDSC DSTRJ RF ABLATION PST NSL NRV
Gross
$17,639
51010334
$11,466
HC NASAL_SINUS NDSC DSTRJ CRYOABLATION PST NSL NRV
Gross
$17,639
50242-145-01
$11,380
PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION [157879]
Gross
$17,508
66733-958-23
$11,323
CETUXIMAB 100 MG/50 ML INTRAVENOUS SOLUTION [37989]
Gross
$17,421
30000199
$10,994
HC EXOME SEQUNECE ANALYSIS
Gross
$16,914
65597-406-01
$10,909
FAM-TRASTUZUMAB DERUXTECAN-NXKI 100 MG INTRAVENOUS SOLUTION [187480]
Gross
$16,782
25682-025-01
$10,823
ULTOMIRIS 100 MG/ML INTRAVENOUS SOLUTION [190117]
Gross
$16,651
0078-0825-81
$10,776
OCTREOTIDE,MICROSPHERES ER 30 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE [170433]
Gross
$16,578
0310-3040-00
$10,725
ANIFROLUMAB-FNIA 300 MG/2 ML (150 MG/ML) INTRAVENOUS SOLUTION [192721]
Gross
$16,500
30000208
$10,235
HC UNLISTED MOLECULAR PATHOLOGY PROC_NEO COMP HEME CANCERS
Gross
$15,746
57894-350-01
$10,223
GOLIMUMAB 12.5 MG/ML INTRAVENOUS SOLUTION [163840]
Gross
$15,728
Showing top 50 of 20,889 priced procedures, sorted by gross charge.

Data straight from this hospital's own published price file (45 CFR § 180). The grade scores how completely the file contains the six required data elements. It is a check of the file — not a CMS compliance ruling, and not a measure of quality of care.